ArticleThe oncologist2026

GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.

Rebecca A Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.